Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL29111089 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL28302955 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL15615 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL15388 | 1.00 | CA4 (0.33) | — | |
| Hydrochloric Acid SCHEMBL44587 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL29121082 | 1.00 | CA4 (0.33) | — | |
| Hydrochloric Acid SCHEMBL42332 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL572002 | 0.87 | — | — | |
| Hydrochloric Acid SCHEMBL15162228 | 0.87 | — | — | |
| Hydrochloric Acid SCHEMBL28587458 | 0.87 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3259 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260096968-A1 | ACTIVE PREMIX CONTAINING ALUMINUM ZIRCONIUM SALTS FOR ANTIPERSPIRANT PRODUCTS | PROCTER & GAMBLE (US) | 2026-04-09 | — | — | US | claimed |
| US-20250248940-A1 | Biopolymer Formulations for Drug Delivery | 11584022 CANADA INC. (CA) | 2025-08-07 | — | — | US | claimed |
| EP-4547280-A1 | BIOPOLYMER FORMULATIONS FOR DRUG DELIVERY | 11584022 Canada Inc. (CA) | 2025-05-07 | — | — | EP | claimed |
| WO-2024248891-A1 | METHODS OF MAKING HIGH PERFORMANCE ALUMINUM-ZIRCONIUM ANTIPERSPIRANT ACTIVE POWDERS CONTAINING CALCIUM AND GLYCINE WITH LOW ZIRCONIUM CONTENT | GULBRANDSEN TECHNOLOGIES, INC. (US) | 2024-12-05 | — | — | WO | claimed |
| US-20240058236-A1 | AN ANTIPERSPIRANT COMPOSITION | CONOPCO, INC., D/B/A UNILEVER (US) | 2024-02-22 | — | — | US | claimed |
| WO-2024003790-A1 | BIOPOLYMER FORMULATIONS FOR DRUG DELIVERY | 11584022 CANADA INC. (CA) | 2024-01-04 | — | — | WO | claimed |
| WO-2023237517-A1 | ANTIPERSPIRANT COMPOSITION | UNILEVER IP HOLDINGS B.V. (NL) | 2023-12-14 | — | — | WO | claimed |
| WO-2023237518-A1 | ANTIPERSPIRANT COMPOSITION | UNILEVER IP HOLDINGS B.V. (NL) | 2023-12-14 | — | — | WO | claimed |
| EP-4259066-A1 | AN ANTIPERSPIRANT COMPOSITION | Unilever IP Holdings B.V. (NL) | 2023-10-18 | — | — | EP | claimed |
| WO-2023078894-A1 | HYGIENE COMPOSITION FOR REDUCTION OF MALODOUR | UNILEVER IP HOLDINGS B.V. (NL) | 2023-05-11 | — | — | WO | claimed |
| EP-0589883-A1 | ENCAPSULATED ANTIPERSPIRANT SALTS AND DEODORANT/ANTIPERSPIRANTS | Revlon Consumer Products Corporation (US) | 1994-04-06 | — | — | EP | claimed |
| US-5271934-A | Encapsulated antiperspirant salts and deodorant/antiperspirants | REVLON CONSUMER PRODUCTS CORPORATION (US) | 1993-12-21 | — | — | US | claimed |
| EP-0491843-A4 | ANTIPERSPIRANT | — | 1993-04-14 | — | — | EP | claimed |
| US-5194262-A | Water soluble shell wall, bioadhesive for sticking to skin | REVLON CONSUMER PRODUCTS CORPORATION (US) | 1993-03-16 | — | — | US | claimed |
| EP-0491843-A1 | ANTIPERSPIRANT. | GILLETTE CO (US) | 1992-07-01 | — | — | EP | claimed |
| WO-1992006672-A1 | ENCAPSULATED ANTIPERSPIRANT SALTS AND DEODORANT/ANTIPERSPIRANTS | REVLON, INC. (US) | 1992-04-30 | — | — | WO | claimed |
| WO-1991004009-A1 | ANTIPERSPIRANT | THE GILLETTE COMPANY (US) | 1991-04-04 | — | — | WO | claimed |
| EP-0396137-A1 | Antiperspirant | The Gillette Company (US) | 1990-11-07 | — | — | EP | claimed |
| US-4774079-A | BUFFERS, ESPECIALLY GLYCINE, ACIDITY | BRISTOL-MYERS COMPANY (US) | 1988-09-27 | — | — | US | claimed |
| EP-0222580-A1 | Antiperspirant formulations containing quaternary ammonium polymer | CALGON CORPORATION (US) | 1987-05-20 | — | — | EP | claimed |